Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226668
Status:
WITHDRAWN
Last Update Posted:
2008-01-03
First Post:
2005-09-23
Brief Title:
XERECEPT hCRF for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Sponsor:
Celtic Pharma Development Services
Organization:
Celtic Pharma Development Services
Organization Data
Organization:
Celtic Pharma Development Services
Class:
INDUSTRY
Study ID:
NTI 0302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celtic Pharma Development Services
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Patrick Rossi MD - Medical Monitor
Old Organization:
Celtic Pharma Development Services
Collaborators
| Name | Class |
|---|---|
| Neurobiological Technologies | INDUSTRY |